Progyny Business Summary

Progyny, Inc. (PGNY) operates as a leading benefits management firm specializing in fertility and family-building solutions for self-insured employers. The company generates revenue through two primary segments: Fertility Benefits, which utilizes a proprietary "Smart Cycle" model to bundle medical services and provider access, and Pharmacy Benefits (Progyny Rx), which provides integrated pharmacy services and care management. Its revenue model is primarily transaction-based, driven by the utilization of services by covered members, supplemented by per-employee-per-month (PEPM) administrative fees. Progyny distinguishes itself in the market through a high-touch clinical advocacy model and a curated network of elite fertility specialists, maintaining a dominant position among Fortune 100 clients while expanding into the mid-market via its Progyny Select offering. Its primary direct competitors include Maven Clinic, Carrot Fertility, and Kindbody, against whom Progyny competes as the only pure-play publicly traded entity with a focus on superior clinical outcomes and cost-containment for large-scale enterprises. Founded in 2008 by Gina Bartasi, the company is currently led by Chief Executive Officer Pete Anevski, who previously served as the firm’s COO and CFO. The executive team includes Chief Financial Officer Mark Livingston, Chief Operating Officer Melissa Cummings (formerly of Blue Cross Blue Shield), Chief Technology Officer Steven Leist (formerly of American Airlines), and Chief Commercial Officer Katie Higgins. This leadership group brings extensive experience in healthcare administration, digital transformation, and insurance operations. The company is supported by a high-profile Board of Directors, including Executive Chairman David Schlanger and representatives from notable institutional investors such as TPG and Kleiner Perkins, who were instrumental in the company’s early-stage venture backing and subsequent 2019 IPO.